Biosamples: Serum

M-BOOST-FR

France
|
2025-2027
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Outpatient clinic
  • Monkeypox virus
  • Mpox
  • Sexually transmitted infection
  • Serum
  • Pharmacological intervention
  • Vaccination
  • MVA-BN

SECOV

Germany
|
2020-2025
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Hospital
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • PBMC
  • Serum

MERMAIDS 2

Serbia Estonia Greece Montenegro Italy Romania Spain The Netherlands
|
2022-2022
  • Adults (18-64 years)
  • Hospital
  • Emergency department
  • SARS-CoV-2
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults (18-64 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Acute COVID-19
  • Blood sample
  • Nasopharyngeal swab
  • PBMC
  • Serum
  • Stool sample
  • Whole blood
  • Plasma

REACT

Spain Denmark South Africa
|
2022-2026
  • Adults (18-64 years)
  • Hospital
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Acute COVID-19
  • Influenza
  • Blood sample
  • PBMC
  • Serum
  • Whole blood
  • Plasma